Bayer Backing Leverage Bayer acquisition as a trust signal to healthcare buyers, emphasizing long-term support, security, and a stable roadmap for enterprise AI deployment across hospitals and radiology networks.

Broad Platform Cross-sell across the platform's 125+ applications and core capabilities by highlighting seamless workflow integration and a relevancy engine that routes the right AI tools to the right studies, reducing care costs and improving diagnostic confidence.

Ecosystem Partnerships Capitalize on a growing partner ecosystem including Quibim, AIRS Medical, Lucida Medical, Avicenna AI, b-rayZ, and the ACR, enabling co-selling and faster market access for complementary imaging AI solutions and benchmarking programs.

Oncology Focus Target oncology programs with an emphasis on prostate cancer imaging by leveraging QP-Prostate, Lucida Pi, and Avicenna CINA-iPE integrations to offer an end-to-end cancer imaging AI workflow.

Market Access Access to large radiology networks through ACR collaboration and the platform's enterprise readiness creates opportunities to win hospital and imaging-center deals seeking standardized AI benchmarking, data registries, and scalable governance.